- Conditions
- Hepatic Encephalopathy, Liver Cirrhosis, Portal Shunt Systemic
- Interventions
- Endoscopic ultrasound-guided transgastric embolization of the spontaneous portosystemic shunts, Interventional Radiology for shunt embolization/retrograde tranvenous obliteration
- Procedure
- Lead sponsor
- Rutgers, The State University of New Jersey
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Newark, New Jersey
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 28
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Peripheral Vascular Disease
- Interventions
- Gelfoam/Thrombin, VascuSeal
- Device
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Waltham, Massachusetts
- Conditions
- Liver Cancer, Metastatic Cancer
- Interventions
- cisplatin, doxorubicin, mitomycin, embolization
- Drug · Procedure
- Lead sponsor
- Eastern Cooperative Oncology Group
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1999 – 2012
- U.S. locations
- 37
- States / cities
- Fort Collins, Colorado • Jacksonville, Florida • Atlanta, Georgia + 18 more
- Conditions
- Spinal Surgery, Vascular Surgery
- Interventions
- rThrombin
- Biological
- Lead sponsor
- ZymoGenetics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 234 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Pasadena, California
- Conditions
- Intraoperative Bleeding
- Interventions
- BioFoam Surgical Matrix, Gelfoam Plus
- Device
- Lead sponsor
- CryoLife, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Seattle, Washington
- Conditions
- Postoperative Hemorrhage
- Interventions
- Fibrocaps (fibrin sealant), Gelfoam
- Device
- Lead sponsor
- Mallinckrodt
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Hemostasis
- Interventions
- ACCEL® Absorbable Hemostat Powder, Gelfoam® (Absorbable Gelatin Sponge, Pfizer Manufacturer Part Number 0342-01)
- Device
- Lead sponsor
- Hemostasis, LLC
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 216 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 5
- States / cities
- Los Angeles, California • Kansas City, Missouri • St Louis, Missouri + 2 more
- Conditions
- Aortic Valve Stenosis, Aneurysm of Ascending Aorta, Aortic Valve Disorder, Bicuspid Valve Disorder
- Interventions
- Progel Vascular Sealant, Gelfoam Plus
- Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 19
- States / cities
- Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 16 more
- Conditions
- Elective Cranial Procedures With Dural Incision
- Interventions
- DuraSeal Dural Sealant System, Standard of Care
- Device · Other
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 237 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Waltham, Massachusetts
- Conditions
- Alveolar Bone Loss
- Interventions
- Tissue Repair Cells (TRC), Control
- Biological · Device
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 20 Years to 70 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Arteriovenous Graft
- Interventions
- SRM003, Participating Site's standard practice
- Biological · Other
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 46
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Fresno, California + 40 more
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Tirapazamine, Doxorubicin
- Drug
- Lead sponsor
- Teclison Ltd.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2024
- U.S. locations
- 3
- States / cities
- Irvine, California • Portland, Oregon • Milwaukee, Wisconsin
- Conditions
- Vascular Disease
- Interventions
- ArterX Surgical Sealant, Gelfoam and Thrombin
- Device
- Lead sponsor
- Tenaxis Medical, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 217 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Greenville, South Carolina
- Conditions
- Tooth Extractions
- Interventions
- Hemcon Dental Dressing, Gauze with Pressure and/or Gelfoam
- Device
- Lead sponsor
- HemCon Medical Technologies, Inc
- Industry
- Eligibility
- 14 Years and older
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- Milwaukie, Oregon • Portland, Oregon
- Conditions
- Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma
- Interventions
- Stereotactic Body Radiation Therapy, Transarterial Chemoembolization, embolic agent, lipiodol
- Radiation · Procedure · Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Hemostasis
- Interventions
- HEMOBLAST Bellows, Absorbable gelatin sponge, USP with thrombin
- Device
- Lead sponsor
- Biom'Up France SAS
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 258 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Los Angeles, California • Pasadena, California + 12 more
- Conditions
- Surgical Hemostasis
- Interventions
- rThrombin, bovine thrombin
- Biological · Drug
- Lead sponsor
- ZymoGenetics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 401 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 29
- States / cities
- Birmingham, Alabama • Arcadia, California • Glendale, California + 21 more
- Conditions
- Metastatic Malignant Neoplasm in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8
- Interventions
- Carmustine, Ethiodized Oil, Transarterial Chemoembolization, Medical Device Usage and Evaluation
- Drug · Procedure · Other
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Arteriovenous Access Grafts or Extra-anatomic and Infra-inguinal Grafts
- Interventions
- Vascular Sealant System, Gelfoam/Thrombin
- Device · Other
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 18 Years and older
- Timeline
- Started 2007
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Operation Site Bleed
- Interventions
- Thrombi-Gel
- Device
- Lead sponsor
- Vascular Solutions LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 7
- States / cities
- Springfield, Illinois • Burlington, Massachusetts • Flint, Michigan + 3 more
- Conditions
- Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic, Neuroendocrine Tumors
- Interventions
- Tirapazamine, Conventional Transarterial Embolization (TAE)
- Drug · Procedure
- Lead sponsor
- Teclison Ltd.
- Industry
- Eligibility
- 20 Years to 99 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2028
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Philadelphia, Pennsylvania
- Conditions
- Tympanoplasty Surgery
- Interventions
- Chitosan succinamide, Gelfoam
- Biological
- Lead sponsor
- Henry Ford Health System
- Other
- Eligibility
- 19 Years to 100 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Novi, Michigan
- Conditions
- Mild or Moderate Surgical Bleeding
- Interventions
- Fibrocaps, Gelatin sponge
- Biological
- Lead sponsor
- Mallinckrodt
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 721 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 29
- States / cities
- Birmingham, Alabama • Los Angeles, California • Orange, California + 24 more
- Conditions
- Surgical Bleeding
- Interventions
- Raplixa, Gelfoam, Rescue treatment
- Drug · Device
- Lead sponsor
- Mallinckrodt
- Industry
- Eligibility
- Up to 17 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 13
- States / cities
- Phoenix, Arizona • Los Angeles, California • Sacramento, California + 10 more